These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 26845950)

  • 1. Impact of a hepatitis C elimination program at a large academic health system.
    Tang R; Boike J; Patel S
    Liver Int; 2023 Sep; 43(9):2042-2043. PubMed ID: 37435687
    [No Abstract]   [Full Text] [Related]  

  • 2. Joint statement in support of hepatitis C human challenge studies.
    Alter HJ; Barnes E; Biondi MJ; Cox AL; Eberts JD; Feld JJ; Liang TJ; Morrison J; Rice CM; Shoukry NH; Thomas DL; Van Gennip J; Weijer C;
    Lancet Gastroenterol Hepatol; 2023 Nov; 8(11):967-969. PubMed ID: 37742699
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal duration of pre-liver transplantation anti-hepatitis C virus treatment with direct-acting agent sofosbuvir.
    Borentain P; Colson P; Darque A; Gérolami R
    Liver Int; 2015 Jun; 35(6):1776. PubMed ID: 25619265
    [No Abstract]   [Full Text] [Related]  

  • 4. Response letter: Just a matter of luck?
    Donato MF; Malinverno F; Monico S
    Liver Int; 2015 Jun; 35(6):1777. PubMed ID: 25676703
    [No Abstract]   [Full Text] [Related]  

  • 5. PRO view: treat to prevent recurrence of HCV.
    Everson GT
    Liver Int; 2015 Jan; 35(1):5-6. PubMed ID: 25729804
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiviral therapy in liver transplant recipients: is SVR the only endpoint that matters?
    Kuo A; Terrault NA
    J Hepatol; 2007 Mar; 46(3):359-61. PubMed ID: 17223220
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment for hepatitis C before and after liver transplantation].
    Ueda Y; Marusawa H
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():306-10. PubMed ID: 26845950
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients.
    Ueda Y; Uemoto S
    Transplantation; 2016 Jan; 100(1):54-60. PubMed ID: 26335914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice.
    McHutchison JG; Bartenschlager R; Patel K; Pawlotsky JM
    J Hepatol; 2006 Feb; 44(2):411-21. PubMed ID: 16364491
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of Direct-Acting Antivirals Compared with Older Agents for Hepatitis C.
    Ta K; Zehtabchi S
    Am Fam Physician; 2017 Jun; 95(11):Online. PubMed ID: 28671433
    [No Abstract]   [Full Text] [Related]  

  • 11. Entry inhibitors and future treatment of hepatitis C.
    Fofana I; Jilg N; Chung RT; Baumert TF
    Antiviral Res; 2014 Apr; 104():136-42. PubMed ID: 24525381
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.